Suppr超能文献

相似文献

1
Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.
Clin J Am Soc Nephrol. 2010 Apr;5(4):576-81. doi: 10.2215/CJN.04710709. Epub 2010 Jan 28.
2
Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
ASAIO J. 2001 Jan-Feb;47(1):82-5. doi: 10.1097/00002480-200101000-00017.
3
Current management of anemia in adult hemodialysis patients with end-stage renal disease.
Am J Health Syst Pharm. 2002 Mar 1;59(5):429-35. doi: 10.1093/ajhp/59.5.429.
5
Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Am J Kidney Dis. 1997 Dec;30(6):912-22. doi: 10.1016/s0272-6386(97)90104-9.
6
7
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.
Am J Kidney Dis. 2009 May;53(5):823-34. doi: 10.1053/j.ajkd.2008.12.040. Epub 2009 Apr 1.
10
A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease.
Clin J Am Soc Nephrol. 2008 Jul;3(4):1015-21. doi: 10.2215/CJN.05681207. Epub 2008 Apr 9.

引用本文的文献

1
Associations between iron markers with hemoglobin and outcomes in peritoneal dialysis patients: results from the PDTAP study.
Clin Kidney J. 2024 Dec 30;18(4):sfae427. doi: 10.1093/ckj/sfae427. eCollection 2025 Apr.
3
Usage of the Anemia Control Model Is Associated with Reduced Hospitalization Risk in Hemodialysis.
Biomedicines. 2024 Sep 28;12(10):2219. doi: 10.3390/biomedicines12102219.
6
A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness.
Korean J Intern Med. 2024 May;39(3):488-500. doi: 10.3904/kjim.2023.520. Epub 2024 Apr 23.
9
Relationship between serum vitamin D3 concentration and anaemia in patients with chronic kidney disease in China.
J Int Med Res. 2021 May;49(5):3000605211012231. doi: 10.1177/03000605211012231.
10
Potential hazards of recent trends in liberal iron use for renal anemia.
Clin Kidney J. 2020 Aug 21;14(1):59-69. doi: 10.1093/ckj/sfaa117. eCollection 2021 Jan.

本文引用的文献

1
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.
Am J Kidney Dis. 2009 May;53(5):823-34. doi: 10.1053/j.ajkd.2008.12.040. Epub 2009 Apr 1.
2
Hemoglobin variability in anemia of chronic kidney disease.
J Am Soc Nephrol. 2009 Mar;20(3):479-87. doi: 10.1681/ASN.2007070728. Epub 2009 Feb 11.
3
Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.
Clin J Am Soc Nephrol. 2008 Nov;3(6):1733-40. doi: 10.2215/CJN.02390508. Epub 2008 Oct 15.
4
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
Kidney Int. 2008 Sep;74(6):791-8. doi: 10.1038/ki.2008.295. Epub 2008 Jul 2.
5
Hemoglobin level variability: associations with mortality.
Clin J Am Soc Nephrol. 2008 Jan;3(1):133-8. doi: 10.2215/CJN.01610407. Epub 2007 Nov 28.
6
Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.
Clin J Am Soc Nephrol. 2008 Jan;3(1):98-104. doi: 10.2215/CJN.03330807. Epub 2007 Nov 28.
7
Hemoglobin variability and mortality in ESRD.
J Am Soc Nephrol. 2007 Dec;18(12):3164-70. doi: 10.1681/ASN.2007010058. Epub 2007 Nov 14.
10
Additional effect of hyperparathyroidism on inflammatory status and rHuEPO requirements in hemodialysis patients.
Transplant Proc. 2006 Nov;38(9):2807-12. doi: 10.1016/j.transproceed.2006.08.104.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验